251 related articles for article (PubMed ID: 10662732)
1. Upregulation of endothelin B receptors in kidneys of DOCA-salt hypertensive rats.
Pollock DM; Allcock GH; Krishnan A; Dayton BD; Pollock JS
Am J Physiol Renal Physiol; 2000 Feb; 278(2):F279-86. PubMed ID: 10662732
[TBL] [Abstract][Full Text] [Related]
2. Effect of chronic treatment with two different ET(A) selective endothelin receptor antagonists on blood pressure and small artery structure of deoxycorticosterone acetate (DOCA)-salt hypertensive rats.
Li JS; Turgeon A; Schiffrin EL
Am J Hypertens; 1998 May; 11(5):554-62. PubMed ID: 9633791
[TBL] [Abstract][Full Text] [Related]
3. ETA receptor blockade attenuates the hypertension but not renal dysfunction in DOCA-salt rats.
Allcock GH; Venema RC; Pollock DM
Am J Physiol; 1998 Jul; 275(1):R245-52. PubMed ID: 9688985
[TBL] [Abstract][Full Text] [Related]
4. Increased renal medullary endothelin-1 synthesis in prehypertensive DOCA- and salt-treated rats.
Hsieh TJ; Lin SR; Lee YJ; Shin SJ; Lai YH; Hsu CH; Tsai JH
Am J Physiol Renal Physiol; 2000 Jul; 279(1):F112-21. PubMed ID: 10894793
[TBL] [Abstract][Full Text] [Related]
5. Direct measurements of endothelium-derived nitric oxide release by stimulation of endothelin receptors in rat kidney and its alteration in salt-induced hypertension.
Hirata Y; Hayakawa H; Suzuki E; Kimura K; Kikuchi K; Nagano T; Hirobe M; Omata M
Circulation; 1995 Feb; 91(4):1229-35. PubMed ID: 7850963
[TBL] [Abstract][Full Text] [Related]
6. Different contributions of endothelin-A and endothelin-B receptors in the pathogenesis of deoxycorticosterone acetate-salt-induced hypertension in rats.
Matsumura Y; Hashimoto N; Taira S; Kuro T; Kitano R; Ohkita M; Opgenorth TJ; Takaoka M
Hypertension; 1999 Feb; 33(2):759-65. PubMed ID: 10024341
[TBL] [Abstract][Full Text] [Related]
7. Decreased endothelin binding and [Ca2+]i signaling in microvessels of DOCA-salt hypertensive rats.
Molero MM; Giulumian AD; Reddy VB; Ludwig LM; Pollock JS; Pollock DM; Rusch NJ; Fuchs LC
J Hypertens; 2002 Sep; 20(9):1799-805. PubMed ID: 12195122
[TBL] [Abstract][Full Text] [Related]
8. Coronary vascular reactivity is improved by endothelin A receptor blockade in DOCA-salt hypertensive rats.
Giulumian AD; Pollock DM; Clarke N; Fuchs LC
Am J Physiol; 1998 Jun; 274(6):R1613-8. PubMed ID: 9608015
[TBL] [Abstract][Full Text] [Related]
9. Altered cardiac endothelin receptors and protein kinase C in deoxycorticosterone-salt hypertensive rats.
Fareh J; Touyz RM; Schiffrin EL; Thibault G
J Mol Cell Cardiol; 2000 Apr; 32(4):665-76. PubMed ID: 10756122
[TBL] [Abstract][Full Text] [Related]
10. Effect of an ET(B)-selective and a mixed ET(A/B) endothelin receptor antagonist on venomotor tone in deoxycorticosterone-salt hypertension.
Johnson RJ; Galligan JJ; Fink GD
J Hypertens; 2001 Mar; 19(3):431-40. PubMed ID: 11288813
[TBL] [Abstract][Full Text] [Related]
11. Down-regulation of soluble guanylyl cyclase in the inner medulla of DOCA-salt hypertensive rats.
Taylor TA; Pollock JS; Pollock DM
Vascul Pharmacol; 2003 Oct; 40(3):155-60. PubMed ID: 13678647
[TBL] [Abstract][Full Text] [Related]
12. Endothelin-1-induced venous contraction is maintained in DOCA-salt hypertension; studies with receptor agonists.
Watts SW; Fink GD; Northcott CA; Galligan JJ
Br J Pharmacol; 2002 Sep; 137(1):69-79. PubMed ID: 12183332
[TBL] [Abstract][Full Text] [Related]
13. Myocardial fibrosis in DOCA-salt hypertensive rats: effect of endothelin ET(A) receptor antagonism.
Ammarguellat F; Larouche I; Schiffrin EL
Circulation; 2001 Jan; 103(2):319-24. PubMed ID: 11208696
[TBL] [Abstract][Full Text] [Related]
14. ETA receptor-mediated role of endothelin in the kidney of DOCA-salt hypertensive rats.
Fujita K; Matsumura Y; Miyazaki Y; Hashimoto N; Takaoka M; Morimoto S
Life Sci; 1996; 58(1):PL1-7. PubMed ID: 8628104
[TBL] [Abstract][Full Text] [Related]
15. Ovarian hormones modulate endothelin-1 vascular reactivity and mRNA expression in DOCA-salt hypertensive rats.
David FL; Carvalho MH; Cobra AL; Nigro D; Fortes ZB; Rebouças NA; Tostes RC
Hypertension; 2001 Sep; 38(3 Pt 2):692-6. PubMed ID: 11566958
[TBL] [Abstract][Full Text] [Related]
16. Selective antagonism of endothelin ET(A) or ET(B) receptor in renal hemodynamics and function of deoxycorticosterone acetate-salt-induced hypertensive rats.
Matsumura Y; Taira S; Kitano R; Hashimoto N; Kuro T
Biol Pharm Bull; 1999 Aug; 22(8):858-62. PubMed ID: 10480326
[TBL] [Abstract][Full Text] [Related]
17. Role of ET-1 receptor binding and [Ca(2+)](i) in contraction of coronary arteries from DOCA-salt hypertensive rats.
Giulumian AD; Molero MM; Reddy VB; Pollock JS; Pollock DM; Fuchs LC
Am J Physiol Heart Circ Physiol; 2002 May; 282(5):H1944-9. PubMed ID: 11959662
[TBL] [Abstract][Full Text] [Related]
18. Endothelin receptor function in mesenteric veins from deoxycorticosterone acetate salt-hypertensive rats.
Johnson RJ; Fink GD; Watts SW; Galligan JJ
J Hypertens; 2002 Apr; 20(4):665-76. PubMed ID: 11910302
[TBL] [Abstract][Full Text] [Related]
19. Activation of the ET-1/ETA pathway contributes to erectile dysfunction associated with mineralocorticoid hypertension.
Carneiro FS; Nunes KP; Giachini FR; Lima VV; Carneiro ZN; Nogueira EF; Leite R; Ergul A; Rainey WE; Clinton Webb R; Tostes RC
J Sex Med; 2008 Dec; 5(12):2793-807. PubMed ID: 18823320
[TBL] [Abstract][Full Text] [Related]
20. Endothelin ET(B) receptor-mediated action on systemic and renal hemodynamics and urine formation in deoxycorticosterone acetate-salt-induced hypertensive rats.
Hashimoto N; Kuro T; Fujita K; Azuma S; Matsumura Y
Biol Pharm Bull; 1998 Aug; 21(8):800-4. PubMed ID: 9743245
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]